Los nuevos anticoagulantes orales presentan mejor relación riesgo­beneficio que la warfarina para la prevención de eventos cardioembólicos en pacientes con fibrilación auricular

Maldonado, Sebastián

Los nuevos anticoagulantes orales presentan mejor relación riesgobeneficio que la warfarina para la prevención de eventos cardioembólicos en pacientes con fibrilación auricular / New anticoagulants have better risk-benefit profile than warfarin for the prevention of embolic events in patients with atrial fibrillation

Maldonado, Sebastián.

Maldonado, Sebastián; Hospital Italiano de Buenos Aires. Servicio de Cardiología. Ciudad Autónoma de Buenos Aires. AR

Evid. actual. práct. ambul ; 19(4): 110-110, 2016. tab

Article in Spanish | LILACS | ID: biblio-1150598

Subject(s)

Humans; Atrial Fibrillation/drug therapy; Anticoagulants/therapeutic use; Atrial Fibrillation/complications; Warfarin/administration & dosage; Warfarin/adverse effects; Warfarin/therapeutic use; Randomized Controlled Trials as Topic; Meta-Analysis as Topic; Administration, Oral; Treatment Outcome; Stroke/etiology; Stroke/prevention & control; Embolism/ethnology; Embolism/prevention & control; Anticoagulants/administration & dosage; Anticoagulants/adverse effects

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Atrial Fibrillation / Anticoagulants Type of study: Controlled clinical trial / Etiology study / Risk factors / Systematic reviews Limits: Humans Language: Spanish Journal: Evid. actual. práct. ambul Journal subject: Medicine / Delivery of Health Care Year: 2016 Type: Article Affiliation country: Argentina Institution/Affiliation country: Hospital Italiano de Buenos Aires/AR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google